In reply: Franke presents some well known problems associated with intravenous administration of large volumes of 0.9% NaCl, particularly its relatively slow elimination (as compared with Hartmann’s solution), and hyperchloraemic acidosis.1 In isolation, we do not dispute these facts. However, 0.9% NaCl is not unique in having problems — no intravenous fluid therapy is without risk, especially when given in excessive volume, or when the composition is inappropriate for the patient’s needs.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- Intensive Care Unit, Alfred Hospital, Melbourne, VIC.
Correspondence: cd@scheinkestel.com.au
- 1. Awad S, Allison, SP, Lobo DN. The history of 0.9% saline. Clin Nutr 2008; 27: 179-188.
- 2. Hilton AK, Pellegrino VA, Scheinkestel CD. Avoiding common problems associated with intravenous fluid therapy. Med J Aust 2008; 189: 509-513. <MJA full text>
Online responses are no longer available. Please refer to our instructions for authors page for more information.